Advanced Research on the Role of Biogenic Amines in Physiological and Pathological Conditions
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 47
Special Issue Editors
Interests: neurodegeneration; neural plasticity; electrophysiology; immunohistochemistr;y neuropharmacology; synaptic plasticity
Special Issues, Collections and Topics in MDPI journals
Interests: metabotropic glutamate receptor 1 (mGluR1); 5-HT7 receptor (5-HT7R); dendritic spines; neuronal primary cultures; structural plasticity; autophagy; synaptopathies; animal models
Special Issues, Collections and Topics in MDPI journals
Interests: cell death; cell physiology; brain tumor; preclinical models; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biogenic amines are a class of neurotransmitters derived from amino acids that are essential for maintaining homeostasis in both the central nervous system (CNS) and the peripheral nervous system (PNS). In the CNS, these neurotransmitters are pivotal for numerous physiological functions, including cognitive processes like learning and memory, regulating emotional responses, and facilitating signal transmission across synapses, impacting overall brain function. Recent research has highlighted the involvement of biogenic amines in various pathological conditions. Imbalances in biogenic amines are linked to mental health disorders such as depression, anxiety, schizophrenia, and neurodegenerative diseases such as Parkinson’s and Alzheimer’s disorders. Moreover, emerging studies suggest a role for biogenic amines in the progression of malignant tumors, such as gliomas.
Understanding how biogenic amines influence brain function presents a complex but promising challenge. Advances in this field could reveal new therapeutic targets and lead to the development of innovative treatments for mental health and neurological well-being.
This Special Issue invites original research and reviews on all aspects of biogenic amines in the CNS. We seek contributions that enhance our understanding of their biological effects and explore their potential therapeutic applications.
Dr. Pellegrino Lippiello
Dr. Luisa Speranza
Dr. Maria Ferraro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biogenic amines
- memory
- synapse
- depression
- anxiety
- schizophrenia
- glioma and neurodegenerative diseases
